The latest update of “Global Viral Vectors and Plasmid DNA Manufacturing Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Viral Vectors and Plasmid DNA Manufacturing Market.
Overview of the Viral Vectors and Plasmid DNA Manufacturing Market:
Molecular biologists often use viral vectors to deliver genetic material inside of cells. These tools can be used in cell culture as well as living organisms. Viruses have developed highly efficient molecular mechanisms for carrying genomes inside cells. Therefore, researchers can easily and effectively deliver DNA, RNA, and other genetic material into cells. While plasmid DNA is a circular piece of DNA that replicates independently of the host chromosomal DNA. They are mostly found in bacteria, but they are also present naturally in archaea and eukaryotes. They provide many functional benefits to their host, such as antibiotic resistance and degradative functions.
Market Drivers:
Growing frequency rate and occurrence of cancer and increasing unmet needs of patients with unusual diseases is expected to boost growth of the global viral vectors and plasmid DNA manufacturing market over the forecast period. According to the World Health Organization (WHO), cancer is a leading cause of death globally accounting for around 10 million deaths in 2020, where breast cancer affects 2.26 million individuals, while lung cancer affected 2.21 million people across the world being the foremost type of cancers affecting people across the globe.
Moreover, growing inclination of patients towards gene therapy is also expected to propel growth of the global viral vectors and plasmid DNA manufacturing market during the forecast period.
Market Restraints:
Factors such as manufacturing challenges affecting the vector production on large scale is expected to hinder growth of the global viral vectors and plasmid DNA manufacturing market over the forecast period.
Regional Insights:
North America is expected to witness significant growth in the global viral vector and plasmid DNA manufacturing market over the forecast period due to key players in the market are introducing novel product approaches for viral vectors. Furthermore, Asia Pacific is also expected to witness strong growth in the market, owing to increasing industrialization, and growing government initiatives for modernizing healthcare infrastructure.
Competitive Section:
Key Players functioning in the global viral vectors and plasmid DNA manufacturing market are Thermo Fisher Scientific, Cobra Biologics, Merck KGaA Inc, Fujifilm Diosynth Biotechnologies, and SIRION Biotech.
In February 2021, SIRION Biotech, a leading company in viral vector-based gene delivery technology entered into collaboration agreement with Sanofi, a leading biopharmaceutical company for the development of improved tissue-selective adeno-associated virus (AAV) vectors to create an effective treatment of gene therapy for diseases that affect major human organs.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Viral Vectors and Plasmid DNA Manufacturing Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Viral Vectors and Plasmid DNA Manufacturing Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Cognate BioServices, Inc. (US)
- Catalent Pharma Solutions (US)
- Fujifilm Holdings Corporation (Japan)
- Johnson & Johnson (US)
- Sanofi Corporation (France)
- Hoffmann-LA Roche Ltd (Switzerland)
- 4D Molecular Therapeutics (US)
- Sirion Biotech GmbH (Germany)
- Voyager Therapeutics (US)
- Thermo Fisher Scientific, Inc. (US)
- Gene Therapy Catapult (UK)
- UniQure(Netherlands)
- MassBiologics (US)
- Renova Therapeutics (US)
- Shenzhen SiBionoGeneTech Co., Ltd (China)
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Viral Vectors and Plasmid DNA Manufacturing Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Plasmid DNA
- Viral Vector
- Non-Viral Vector
By Applications, the market is segmented into:
- Antisense & RNAi Therapy
- Gene Therapy
- Cell Therapy
- Vaccinology
- Research
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Viral Vectors and Plasmid DNA Manufacturing Market
1.6.1 How the Covid-19 is Affecting the Viral Vectors and Plasmid DNA Manufacturing Market
1.6.1.1 Viral Vectors and Plasmid DNA Manufacturing Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Viral Vectors and Plasmid DNA Manufacturing Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2015-2028)
2.2 Viral Vectors and Plasmid DNA Manufacturing Market Growth Trends by Regions
2.2.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Market Historic Market Share by Regions (2015-2021)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Viral Vectors and Plasmid DNA Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Vectors and Plasmid DNA Manufacturing Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Market Players by Market Size
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Market Players by Revenue (2015-2021)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Market Revenue in 2019
3.3 Viral Vectors and Plasmid DNA Manufacturing Market Key Players Head office and Area Served
3.4 Key Players Viral Vectors and Plasmid DNA Manufacturing Market Product Solution and Service
3.5 Date of entering into Viral Vectors and Plasmid DNA Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Historic Market Size by Type (2015-2021)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecasted Market Size by Type (2021-2028)
5 Viral Vectors and Plasmid DNA Manufacturing Market Breakdown Data by Application (2015-2028)
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2021)
6.2 Viral Vectors and Plasmid DNA Manufacturing Market Key Players in North America (2019-2021)
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2021)
7.2 Viral Vectors and Plasmid DNA Manufacturing Market Key Players in Europe (2019-2021)
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
8 China
8.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2021)
8.2 Viral Vectors and Plasmid DNA Manufacturing Market Key Players in China (2019-2021)
8.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021)
8.4 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
9 Japan
9.1 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2021)
9.2 Viral Vectors and Plasmid DNA Manufacturing Market Key Players in Japan (2019-2021)
9.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021)
9.4 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2021)
10.2 Viral Vectors and Plasmid DNA Manufacturing Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021)
10.4 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
11 India
11.1 India Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2021)
11.2 Viral Vectors and Plasmid DNA Manufacturing Market Key Players in India (2019-2021)
11.3 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021)
11.4 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2021)
12.2 Viral Vectors and Plasmid DNA Manufacturing Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021)
12.4 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Viral Vectors and Plasmid DNA Manufacturing Market Introduction
13.4 Viral Vectors and Plasmid DNA Manufacturing Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Viral Vectors and Plasmid DNA Manufacturing Market Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Market Revenue
Table 3. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Viral Vectors and Plasmid DNA Manufacturing Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Viral Vectors and Plasmid DNA Manufacturing Market Players to Combat Covid-19 Impact
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions (2015-2021)
Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Viral Vectors and Plasmid DNA Manufacturing Market Growth Strategy
Table 20. Main Points Interviewed from Key Viral Vectors and Plasmid DNA Manufacturing Market Players
Table 21. Global Viral Vectors and Plasmid DNA Manufacturing Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2015-2021)
Table 23. Global Top Viral Vectors and Plasmid DNA Manufacturing Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing Market as of 2019)
Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Viral Vectors and Plasmid DNA Manufacturing Market Product Solution and Service
Table 27. Date of entering into Viral Vectors and Plasmid DNA Manufacturing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2015-2021)
Table 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Revenue Market Share by Type (2021-2028)
Table 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2015-2021)
Table 33. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 34. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2028)
Table 35. North America Key Players Viral Vectors and Plasmid DNA Manufacturing Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2021)
Table 37. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 38. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2021)
Table 39. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 40. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2021)
Table 41. Europe Key Players Viral Vectors and Plasmid DNA Manufacturing Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2021)
Table 43. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2021)
Table 45. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2021)
Table 47. China Key Players Viral Vectors and Plasmid DNA Manufacturing Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2021)
Table 49. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 50. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2021)
Table 51. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 52. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2021)
Table 53. Japan Key Players Viral Vectors and Plasmid DNA Manufacturing Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2021)
Table 55. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2021)
Table 57. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Viral Vectors and Plasmid DNA Manufacturing Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2021)
Table 61. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2021)
Table 63. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2021)
Table 65. India Key Players Viral Vectors and Plasmid DNA Manufacturing Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2021)
Table 67. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 68. India Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2021)
Table 69. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 70. India Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Viral Vectors and Plasmid DNA Manufacturing Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2021)
Table 73. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2021)
Table 75. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Viral Vectors and Plasmid DNA Manufacturing Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Viral Vectors and Plasmid DNA Manufacturing Market Report Years Considered
Figure 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions: 2021 VS 2028
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2019
Figure 13. Global Top Viral Vectors and Plasmid DNA Manufacturing Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Market Revenue in 2019
Figure 15. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
